Drug screening in a zebrafish model of duchenne muscular dystrophy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 13, 2011, Pages 5331-5336

  Kawahara, Genri ^a,b   Karpf, Jeremy A ^a,b   Myers, Jennifer A ^a,b,c   Alexander, Matthew S ^a,b,c   Guyone, Jeffrey R ^d   Kunkel, Louis M ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Recruitment Energetics and Coastal Assessment Program   (United States)

Author keywords

Chemical treatment; Phosphodiesterase inhibitor

Indexed keywords

AMINOPHYLLINE; ANTIALLERGIC AGENT; CONESSINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPYRIDAMOLE; DYSTROPHIN; ENOXIMONE; EPIRIZOLE; EQUILIN; HOMOCHLORCYCLIZINE DIHYDROCHLORIDE; IBUDILAST; MILRINONE; PENTETIC ACID; PROSCILLARIDIN; ROLIPRAM; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIREFRINGENCE; CONFERENCE PAPER; DRUG MECHANISM; DRUG SCREENING; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; GENOTYPE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ZEBRA FISH;

ANIMALIA; DANIO RERIO;

EID: 79955100665     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1102116108     Document Type: Article

References (31)

1. Monaco AP, et al. (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646-650. (Pubitemid 16008561)
2. Burghes AH, et al. (1987) A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 328:434-437. (Pubitemid 17097776)
3. Welch EM, et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:87-91. (Pubitemid 46685839)
4. Bogdanovich S, et al. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418-421. (Pubitemid 35415652)
5. Lu QL, et al. (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 9:1009-1014. (Pubitemid 37021780)
6. van Deutekom JC, et al. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357:2677-2686.
7. Dooley K, Zon LI (2000) Zebrafish: A model system for the study of human disease.Curr Opin Genet Dev 10:252-256. (Pubitemid 30307241)
8. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44. (Pubitemid 40109588)
9. Pichler FB, et al. (2003) Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol 21:879-883. (Pubitemid 36936192)
10. Stern HM, et al. (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1:366-370.
11. Peterson RT, Link BA, Dowling JE, Schreiber SL (2000) Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 97:12965-12969.
12. Bassett DI, Currie PD (2003) The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum Mol Genet 12:R265-R270. (Pubitemid 37259341)
13. Guyon JR, et al. (2005) Delta-sarcoglycan is required for early zebrafish muscle organization. Exp Cell Res 304:105-115. (Pubitemid 40222080)
14. Guyon JR, et al. (2003) The dystrophin associated protein complex in zebrafish. Hum Mol Genet 12:601-615. (Pubitemid 36378105)
15. Guyon JR, et al. (2009) Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin. Hum Mol Genet 18:202-211.
16. Moore CJ, Goh HT, Hewitt JE (2008) Genes required for functional glycosylation of dystroglycan are conserved in zebrafish. Genomics 92:159-167.
17. Thornhill P, Bassett D, Lochmüller H, Bushby K, Straub V (2008) Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP). Brain 131:1551-1561. (Pubitemid 351806461)
18. Kawahara G, Guyon JR, Nakamura Y, Kunkel LM (2010) Zebrafish models for human FKRP muscular dystrophies. Hum Mol Genet 19:623-633.
19. Steffen LS, et al. (2007) Zebrafish orthologs of human muscular dystrophy genes. BMC Genomics 8:79.
20. Adamo CM, et al. (2010) Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA 107:19079-19083.
21. Kobayashi YM, et al. (2008) Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 456:511-515. (Pubitemid 352759004)
22. Barnes PJ (2003) Theophylline: New perspectives for an old drug. Am J Respir Crit Care Med 167:813-818. (Pubitemid 36801766)
23. Luo WJ, Ling X, Huang RM (2004) Effects of aminophylline on cytokines and pulmonary function in patients undergoing valve replacement. Eur J Cardiothorac Surg 25:766-771. (Pubitemid 38481990)
24. Sullivan P, et al. (1994) Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343:1006-1008. (Pubitemid 24122609)
25. Mahomed AG, Theron AJ, Anderson R, Feldman C (1998) Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A. Inflammation 22:545-557. (Pubitemid 28524066)
26. Asai A, et al. (2007) Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS ONE 2:e806.
27. Willoughby D, Wong W, Schaack J, Scott JD, Cooper DM (2006) An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J 25:2051-2061.
28. Chen AE, Ginty DD, Fan CM (2005) Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317-322.
29. Johnson BD, Scheuer T, Catterall WA (2005) Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. Proc Natl Acad Sci USA 102:4191-4196. (Pubitemid 40388578)
30. Nusslein-Volhard C, Dahm R (2002) Zebrafish: A Practical Approach (Oxford University Press, Oxford).
31. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203:253-310